AELIX Therapeutics enrolls first patient in company’s initial therapeutic HIV vaccine clinical trial 05/09/2017 AELIX-002 phase I study will focus on evaluating the safety and immunogenicity of the HTI vaccine. 0READ Promising advances in the fight against AIDS 25/04/2017 The latest results suggest that we are closer to a definitive solution for HIV. 0READ
Promising advances in the fight against AIDS 25/04/2017 The latest results suggest that we are closer to a definitive solution for HIV. 0READ
0
READ